Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
AssigneeB.R.A.H.M.S GmbH
InventorsAndreas Bergmann, Oliver Hartmann, Frauke Hein, Beat Müller
Life of this patent
Estimating the term…
Abstract
The present invention relates to an in vitro method for the diagnosis and treatment guidance of a bacterial infection in patients suffering from an acute ischemic or hemorrhagic stroke, comprising the determination of the level of Procalcitonin (PCT) or a fragment thereof having at least 12 amino acid residues in a sample of a bodily fluid from said patient and the correlation of the determined level to the diagnosis of a bacterial infection in said patient.
Claims14
A method for diagnosing a bacterial infection in a patient who has suffered from an acute stroke or from a transient ischemic attack, comprising the steps of:
- (i) providing a sample from a patient who has suffered from an acute stroke or a transient ischemic attack wherein the sample was taken from said patient earlier than 72 hours after the onset of acute stroke or transient ischemic attack symptoms;
- (ii) determining the level of Procalcitonin (PCT) or a fragment thereof of at least 12 amino acids in length in said sample using a PCT detection assay with a functional assay sensitivity of below 0.06 ng/mL;
- and
- (iii) determining whether said patient has a bacterial infection or not by comparing said determined PCT level with a predetermined threshold level.
Dependencies are inferred from the claim text.